Ceretec

scintigraphy, Cerebrovascular accident, Leukocytes + 2 more
Treatment
8 FDA approvals
19 Active Studies for Ceretec

What is Ceretec

Technetium Tc-99m exametazimeThe Generic name of this drug
Treatment SummaryTechnetium Tc-99m exametazime is a radioactive medicine sold under the name Ceretec. It is used to check for changes in how the brain is getting blood, which can help diagnose stroke and other brain diseases. Exametazime can also be used to find infections or inflammation in the abdomen. It works by attaching to the Tc-99m radioisotope, which can then be tracked and monitored.
Ceretecis the brand name
Ceretec Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Ceretec
Technetium Tc-99m exametazime
1988
4

Approved as Treatment by the FDA

Technetium Tc-99m exametazime, also called Ceretec, is approved by the FDA for 8 uses including Abdominal Infection and altered regional cerebral perfusion in stroke .
Abdominal Infection
altered regional cerebral perfusion in stroke
Inflammatory Bowel Diseases (IBD)
Leukocytes
scintigraphy
Cerebrovascular accident
Intraabdominal Infections
Crohn's Disease

Effectiveness

How Ceretec Affects PatientsAfter being injected with a special kind of leukocytes, Tc99m will show up in the lungs, liver, spleen, blood pool, bone marrow, and bladder within an hour. It may also be seen in the kidneys and gall bladder. After 1-6 hours, activity in the bowel can be seen. After 24 hours, substantial activity will be visible in the colon.

When to interrupt dosage

The prescribed dosage of Ceretec is contingent upon the diagnosed condition, such as Crohn's Disease and Ulcerative Colitis, Cerebrovascular accident and scintigraphy. The degree of dosage is subject to the procedure of delivery, which is outlined in the table underneath.
Condition
Dosage
Administration
scintigraphy
, 0.5 mg/mL, 0.5 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Kit
Cerebrovascular accident
, 0.5 mg/mL, 0.5 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Kit
Leukocytes
, 0.5 mg/mL, 0.5 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Kit
Intraabdominal Infections
, 0.5 mg/mL, 0.5 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Kit
Crohn's Disease
, 0.5 mg/mL, 0.5 mg
, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Kit

Warnings

There are 20 known major drug interactions with Ceretec.
Common Ceretec Drug Interactions
Drug Name
Risk Level
Description
Acrivastine
Minor
Technetium Tc-99m exametazime may decrease the excretion rate of Acrivastine which could result in a higher serum level.
Albutrepenonacog alfa
Minor
Technetium Tc-99m exametazime may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
Almasilate
Minor
Technetium Tc-99m exametazime may decrease the excretion rate of Almasilate which could result in a higher serum level.
Antihemophilic factor (recombinant), PEGylated
Minor
Technetium Tc-99m exametazime may decrease the excretion rate of Antihemophilic factor (recombinant), PEGylated which could result in a higher serum level.
Antithrombin III human
Minor
Technetium Tc-99m exametazime may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.

Ceretec Novel Uses: Which Conditions Have a Clinical Trial Featuring Ceretec?

25 active clinical trials are presently analyzing the efficacy of Ceretec in treating Crohn's Disease and Ulcerative Colitis, Intraabdominal Infections and Scintigraphic Imaging.
Condition
Clinical Trials
Trial Phases
Intraabdominal Infections
1 Actively Recruiting
Not Applicable
Cerebrovascular accident
0 Actively Recruiting
Leukocytes
0 Actively Recruiting
scintigraphy
0 Actively Recruiting
Crohn's Disease
18 Actively Recruiting
Phase 1, Not Applicable, Early Phase 1, Phase 2, Phase 4

Patient Q&A Section about ceretec

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the generic name for Ceretec?

"Technetium Tc-99m exametazime is a radiopharmaceutical that goes by the trade name Ceretec. It is used in the detection of altered regional cerebral perfusion in stroke and other cerebrovascular diseases."

Answered by AI

Is Ceretec an Hmpao?

"Tc-99m HMPAO is a glucose analog.

Tc-99m HMPAO (Tc-99m exametazime [Ceretec]) was first introduced in the mid-1980s as a glucose analog."

Answered by AI

How is Ceretec supplied?

"The Ceretec kit comes with 5 vials to use in the preparation of a technetium Tc99m exametazime intravenous injection. This is a diagnostic radiopharmaceutical that can help detect altered regional cerebral perfusion and radiolabel autologous leukocytes."

Answered by AI

What is Ceretec used for?

"CERETEC is especially useful for imaging patients with epilepsy that start in the center and back part of the ears. It can help diagnose the condition, but it cannot be used to treat or cure epilepsy. There may be other reasons why your doctor prescribed it for you."

Answered by AI

Clinical Trials for Ceretec

Have you considered Ceretec clinical trials? We made a collection of clinical trials featuring Ceretec, we think they might fit your search criteria.
Have you considered Ceretec clinical trials? We made a collection of clinical trials featuring Ceretec, we think they might fit your search criteria.
Have you considered Ceretec clinical trials? We made a collection of clinical trials featuring Ceretec, we think they might fit your search criteria.